Alpha Sense BI

AUGUST 30, 2023

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market.

Management 98

Management Due Diligence Biotech Algorithm 98

Alpha Sense BI

MAY 28, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. Instead, experts agree that investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams.

Capital 69

Capital Startups Due Diligence Biotech 69

BIS Research

MARCH 19, 2019

Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy. billion by 2028.

Globalization 64

Globalization Biotech Marketing Marketing 64

Alpha Sense BI

MAY 5, 2023

M&A Trends by Industry Healthcare The COVID-19 pandemic ushered in a wave of unprecedented innovation, progress, and transformation to the healthcare industry in 2020. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines. Start your free trial today.

Biotech 97

Biotech Capital Banking Startups 97

Sedulo

MARCH 15, 2023

By leveraging our proprietary approach to research and insight development, our skilled team of competitive strategy professionals follows a systematic “Four I’s” process to gather Information, analyze Intelligence, uncover Insights, and contextualize Implications. Assess and benchmark enrollment timing.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. Inflationary pressures are forecasted to ease and new innovations are capturing the attention of consumers, investors, and executives across various industries. As we navigate 2024, the landscape appears positioned for a triumphant comeback.

Technology 69

Technology Technology Retail Due Diligence 69

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Engage3

MAY 19, 2022

Ken served on the Board of Directors of Revionics between 2007-2011 and as Chief Scientist & VP of Innovations at SAP AG between 2006-2007. Tim Ouimet Founder & Board Observer Tim Ouimet is a Founder and Board Member at Engage3 and is a recognized industry innovator in retail pricing strategies.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

JUNE 6, 2024

Whether you’re looking to refine your market strategy, innovate more effectively, or enhance your competitive advantage, mastering competitor analysis is your key to sustained success and growth. This means you can shave hours of time off your research and be more confident in the accuracy and comprehensiveness of your results.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 370

Biotech Innovation Research Technology 370

CIO

MARCH 4, 2025

CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. As a business executive who has led ventures in areas such as space technology or data security and helped bridge research and industry, Ive seen first-hand how rapidly deep tech is moving from the lab into the heart of business strategy.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, HATCo announced its intent to acquire Summa Health of Ohio , a non-profit healthcare system, with a focus to “put innovation in.”

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. But with so many options for market research, from traditional focus group facilities to modern research platforms, finding the right partner isn’t always straightforward.

Market Research 52

Market Research Marketing Research Research Marketing 52

Alpha Sense BI

MARCH 14, 2025

Biotech Funding Healthcare and biotech have experienced ongoing funding dryspells, with public funding down 56% for biotechnology companies in January of this year. However, according to broker research from the AlphaSense platform, robust VC funding helped offset an otherwise down month for biotech funding.

Capital 59

Capital Biotech Startups Finance 59

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Attest approaches market research differently.

Market Research 52

Market Research Marketing Research Research Marketing 52

Alpha Sense BI

FEBRUARY 6, 2025

Leading broker research in the AlphaSense platform referred to it as the biggest software deal of 2024. According to Synopsys, customers are feeling optimistic about the acquisition, as the combined company will be able to drive innovation across industries by addressing the growing need for integrated system design solutions.

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Alpha Sense BI

APRIL 3, 2025

Concurrently, smaller biotech firms and midsized companies offering promising innovations, particularly in high-demand therapeutic areas such as oncology, immunology, neuroscience, and cardio-metabolic conditions, are expected to become highly attractive targets. How will tariff policies play out?

Biotech 52

Biotech Pharmaceutical Loss Research 52

Alpha Sense BI

JANUARY 8, 2025

At the same time, the outlook for therapeutic innovation remains bright. In this blog, we leverage proprietary expert interviews from the AlphaSense market research platform to understand the top trends shaping the healthcare landscape in 2025. Kennedy Jr. Below, we cover the likely effects of expected policies on these three groups.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69